Activity of second‐generation ALK inhibitors against crizotinib‐resistant mutants in an NPM‐ALK model compared to EML4‐ALKDiletta Fontana, Luca Mologni|Cancer Medicine|2015Cited by 88
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamineDiletta Fontana, Rocco Piazza|Nature Communications|2020Cited by 49